Liquid metal (LM) bioelectronics find widespread uses in healthcare devices and medical implants. However, the current LM‐based electrodes suffer from achieving a combination of features including stable conductivity, high tissue adhesion, stability, good biocompatibility, degradability, and recyclability. In this work, a stable LM electrode is prepared with an extremely high adhesion strength (8.9 MPa), which is tunable in a wide range by introducing an adhesive ureidopyrimidinone (UPy)‐based polymer to harvest the abovementioned properties. With the help of dynamic LM particle‐polymer interactions in the polymer matrix, LMs can not only enhance the adhesion properties but also form a percolated network at a low LM loading (38 vol%) to achieve a high conductance stability (R/R₀ = 0.76 at 100% strain). The high adhesion strength provides a highly stable electrical connection with rigid components with a high stretchability of 1154% when mounting a resistor, while a relatively low adhesion makes it a comfortable wounded skin‐interfaced electrode for accelerating wound healing. Taking advantage of their tunable surface adhesion and biocompatibility, the as‐prepared LM electrodes provide a more reliable and friendly approach to the development of healthcare devices.

The emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) causing high mortality in clinical patients infers the urgent need for developing therapeutic agents. Here, we demonstrated vitamin C (VC) exhibited strong bactericidal, anti-biofilm, and virulence-suppressing effects on CR-hvKP. Our results showed such a bactericidal effect is dose-dependent both in vitro and in the mouse infection model and is associated with induction of reactive oxygen species (ROS) generation. In addition, VC inhibited biofilm formation of CR-hvKP through suppressing the production of exopolysaccharide (EPS). In addition, VC acted as an efflux pump inhibitor at subminimum inhibitory concentration (sub-MIC) to disrupt transportation of EPS and capsular polysaccharide to bacterial cell surface, thereby further inhibiting biofilm and capsule formation. Furthermore, virulence-associated genes in CR-hvKP exposed to sub-MIC of VC were downregulated. Our findings indicated VC could be an effective and safe therapeutic agent to treat CR-hvKP infections in urgent cases when all current treatment options fail.